Evidence for oxidative stress in NSAID-induced colitis in IL10-/- mice

Free Radical Biology and Medicine

Volumn 34, Issue 9, 2003, Pages 1153-1166

  Narushima, Seiko ^a   Spitz, Douglas R ^a   Oberley, Larry W ^a   Toyokuni, Shinya ^b   Miyata, Toshio ^c   Gunnett, Carol A ^a   Buettner, Garry R ^a   Zhang, Juan ^a   Ismail, Hanan ^a   Lynch, Richard G ^a   Berg, Daniel J ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Free radicals; Inflammatory bowel disease; Interleukin 10; Nonsteroidal anti inflammatory drug; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALLOPURINOL; DIPHENYLIODONIUM SALT; FLAVOPROTEIN; INDOMETACIN; INTERLEUKIN 10; LUCIGENIN; N(G) NITROARGININE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; QUERCETIN;

ANIMAL MODEL; ARTICLE; CHEMOLUMINESCENCE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; GLYCATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REDUCTION; STAINING; WILD TYPE;

EID: 0037403593     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00065-0     Document Type: Article

References (68)

1. Sedghi S., Fields J.Z., Klamut M., Urban G., Durkin M., Winship D., Fretland D., Olyaee M., Keshavarzian A. Increased production of luminol enhanced chemiluminescence by the inflamed colonic mucosa in patients with ulcerative colitis. Gut. 34:1993;1191-1197.
2. Simmonds N.J., Allen R.E., Stevens T.R., Van Someren R.N., Blake D.R., Rampton D.S. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology. 103:1992;186-196.
3. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., Stenson W.F. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology. 111:1996;871-885.
4. Sachar D.B. Cancer in Crohn's disease dispelling the myths . Gut. 35:1994;1507-1508.
5. Ransohoff D.F. Colon cancer in ulcerative colitis. Gastroenterology. 94:1988;1089-1091.
6. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
7. Laichalk L.L., Danforth J.M., Standiford T.J. Interleukin-10 inhibits neutrophil phagocytic and bactericidal activity. FEMS Immunol. Med. Microbiol. 15:1996;181-187.
8. Kuga S., Otsuka T., Niiro H., Nunoi H., Nemoto Y., Nakano T., Ogo T., Umei T., Niho Y. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp. Hematol. 24:1996;151-157.
9. Berg D.J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., Thompson-Snipes L., Leach M.W., Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98:1996;1010-1020.
10. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., Rennick D.M. IL12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL10-deficient mice. J. Immunol. 161:1998;3143-3149.
11. Davidson N.J., Leach M.W., Fort M.M., Thompson-Snipes L., Kuhn R., Muller W., Berg D.J., Rennick D.M. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin-10-deficient mice. J. Exp. Med. 184:1996;241-251.
12. Schreiber S., Fedorak R.N., Nielsen O.H., Wild G., Williams C.N., Nikolaus S., Jacyna M., Lashner B.A., Gangl A., Rutgeerts P., Isaacs K., van Deventer S.J., Koningsberger J.C., Cohard M., LeBeaut A., Hanauer S.B. Safety and efficacy of recombinant human interleukin-10 in chronic active Crohn's disease. Crohn's disease IL10 cooperative study group. Gastroenterology. 119:2000;1461-1472.
13. Berg D.J., Zhang J., Weinstock J.V., Ismail H.F., Earle K.A., Alila H., Pamukcu R., Moore S., Lynch R.G. Rapid development of colitis in NSAID-treated IL10-deficient mice. Gastroenterology. 123:2002;1527-1542.
14. Sekhar K.R., Spitz D.R., Harris S., Nguyen T.T., Meredith M.J., Holt J.T., Guis D., Marnett L.J., Summar M.L., Freeman M.L. Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of γ-glutamylcysteine synthetase. Free Radic. Biol. Med. 32:2002;650-662.
15. Bjarnason I., Hayllar J., MacPherson A.J., Russell A.S. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 104:1993;1832-1847.
16. Kaufmann H.J., Taubin H.L. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann. Intern. Med. 107:1987;513-516.
17. Millar A.D., Rampton D.S., Chander C.L., Claxson A.W., Blades S., Coumbe A., Panetta J., Morris C.J., Blake D.R. Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut. 39:1996;407-415.
18. Keshavarzian A., Sedghi S., Kanofsky J., List T., Robinson C., Ibrahim C., Winship D. Excessive production of reactive oxygen metabolites by inflamed colon analysis by chemiluminescence probe . Gastroenterology. 103:1992;177-185.
19. Yue G., Sun F.F., Dunn C., Yin K., Wong P.Y. The 21-aminosteroid tirilazad mesylate can ameliorate inflammatory bowel disease in rats. J. Pharmacol. Exp. Ther. 276:1996;265-270.
20. Didion S.P., Faraci F.M. Effects of NADH and NADPH on superoxide levels and cerebral vascular tone. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H688-H695.
21. Gunnett C.A., Heistad D.D., Berg D.J., Faraci F.M. IL10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H1555-H1562.
22. Gantt K.R., Goldman T.L., McCormick M.L., Miller M.A., Jeronimo S.M., Nascimento E.T., Britigan B.E., Wilson M.E. Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J. Immunol. 167:2001;893-901.
23. Kennedy M.C., Emptage M.H., Dreyer J.L., Beinert H. The role of iron in the activation-inactivation of aconitase. J. Biol. Chem. 258:1983;11098-11105.
24. Drapier J.C., Hibbs J.B. Jr. Aconitases a class of metalloproteins highly sensitive to nitric oxide synthesis . Methods Enzymol. 269:1996;26-36.
25. Rose I.A., O'Connell E.L. Mechanism of aconitase action. I. The hydrogen transfer reaction. J. Biol. Chem. 242:1967;1870-1879.
26. Anderson M.E. Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol. 113:1985;548-555.
27. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
28. Miyata T., Taneda S., Kawai R., Ueda Y., Horiuchi S., Hara M., Maeda K., Monnier V.M. Identification of pentosidine as a native structure for advanced glycation endproducts in β-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. USA. 93:1996;2353-2358.
29. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H., Strihou C.Y., Monnier V.M., Witztum J.L., Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 100:1997;2995-3004.
30. Toyokuni S., Tanaka T., Hattori Y., Nishiyama Y., Yoshida A., Uchida K., Hiai H., Ochi H., Osawa T. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1 its application to ferric nitrilotriacetate-induced renal carcinogenesis model . Lab. Invest. 76:1997;365-374.
31. Miesel R., Kurpisz M., Kroger H. Suppression of inflammatory arthritis by simultaneous inhibition of nitric oxide synthase and NADPH oxidase. Free Radic. Biol. Med. 20:1996;75-81.
32. Gardner P.R., Nguyen D.D., White C.W. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc. Natl. Acad. Sci. USA. 91:1994;12248-12252.
33. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269:1994;29405-29408.
34. Berg D.J., Zhang J., Lauricella D.M., Moore S.A. IL10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J. Immunol. 166:2001;2674-2680.
35. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin-10 (IL10) inhibits cytokine synthesis by human monocytes an autoregulatory role of IL10 produced by monocytes . J. Exp. Med. 174:1991;1209-1220.
36. Dokka S., Shi X., Leonard S., Wang L., Castranova V., Rojanasakul Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L1196-L1202.
37. Davies G.R., Simmonds N.J., Stevens T.R., Sheaff M.T., Banatvala N., Laurenson I.F., Blake D.R., Rampton D.S. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut. 35:1994;179-185.
38. Williams A.J., Cole P.J. The onset of polymorphonuclear leucocyte membrane-stimulated metabolic activity. Immunology. 43:1981;733-739.
39. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.L., Trush M.A. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J. Biol. Chem. 273:1998;2015-2023.
40. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82.
41. Kikuchi H., Hikage M., Miyashita H., Fukumoto M. NADPH oxidase subunit, gp91(phox) homologue, preferentially expressed in human colon epithelial cells. Gene. 254:2000;237-243.
42. Esworthy R.S., Aranda R., Martin M.G., Doroshow J.H., Binder S.W., Chu F.F. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G848-G855.
43. Nieto N., Torres M.I., Fernandez M.I., Giron M.D., Rios A., Suarez M.D., Gil A. Experimental ulcerative colitis impairs antioxidant defense system in rat intestine. Dig. Dis. Sci. 45:2000;1820-1827.
44. Sanchez de Medina F., Galvez J., Romero J.A., Zarzuelo A. Effect of quercitrin on acute and chronic experimental colitis in the rat. J. Pharmacol. Exp. Ther. 278:1996;771-779.
45. Zea-Iriarte W.L., Makiyama K., Goto S., Murase K., Urata Y., Sekine I., Hara K., Kondo T. Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide. Scand. J. Gastroenterol. 31:1996;985-992.
46. Ardite E., Sans M., Panes J., Romero F.J., Pique J.M., Fernandez-Checa J.C. Replenishment of glutathione levels improves mucosal function in experimental acute colitis. Lab. Invest. 80:2000;735-744.
47. Holmes E.W., Yong S.L., Eiznhamer D., Keshavarzian A. Glutathione content of colonic mucosa evidence for oxidative damage in active ulcerative colitis . Dig. Dis. Sci. 43:1998;1088-1095.
48. Yan L.J., Levine R.L., Sohal R.S. Oxidative damage during aging targets mitochondrial aconitase. Proc. Natl. Acad. Sci. USA. 94:1997;11168-11172.
49. Gardner P.R., Raineri I., Epstein L.B., White C.W. Superoxide radical and iron modulate aconitase activity in mammalian cells. J. Biol. Chem. 270:1995;13399-13405.
50. •-), superoxide dismutases, and related matters. J. Biol. Chem. 272:1997;18515-18517.
51. Miyata T., Kurokawa K., Van Ypersele De Strihou C. Advanced glycation and lipoxidation endproducts role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism . J. Am. Soc. Nephrol. 11:2000;1744-1752.
52. Miyata T., Van Ypersele De Strihou C., Kurokawa K., Baynes J.W. Alterations in nonenzymatic biochemistry in uremia origin and significance of "carbonyl stress" in long-term uremic complications . Kidney Int. 55:1999;389-399.
53. ε- (carboxymethyl)lysine on proteins a mechanism for producing advanced glycation endproducts at sites of inflammation . J. Clin. Invest. 104:1999;103-113.
54. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
55. ε-(carboxymethyl)lysine in lens proteins . Biochemistry. 28:1989;9464-9468.
56. Kimura H., Hokari R., Miura S., Shigematsu T., Hirokawa M., Akiba Y., Kurose I., Higuchi H., Fujimori H., Tsuzuki Y., Serizawa H., Ishii H. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut. 42:1998;180-187.
57. Cunha F.Q., Moncada S., Liew F.Y. Interleukin-10 (IL10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182:1992;1155-1159.
58. Roilides E., Dimitriadou A., Kadiltsoglou I., Sein T., Karpouzas J., Pizzo P.A., Walsh T.J. IL10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Immunol. 158:1997;322-329.
59. Berg, D. J.; Zhang, J.; Lauricella, D.; Moore, S. A. Interleukin-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J. Immunol. 166:2674-2680; 2001.
60. Berg D.J., Kuhn R., Rajewsky K., Muller W., Menon S., Davidson N., Grunig G., Rennick D. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J. Clin. Invest. 96:1995;2339-2347.
61. Hokari R., Kato S., Matsuzaki K., Kuroki M., Iwai A., Kawaguchi A., Nagao S., Miyahara T., Itoh K., Sekizuka E., Nagata H., Ishii H., Miura S. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic. Biol. Med. 31:2001;153-163.
62. Dikopoulos N., Nussler A.K., Liptay S., Bachem M., Reinshagen M., Stiegler M., Schmid R.M., Adler G., Weidenbach H. Inhibition of nitric oxide synthesis by aminoguanidine increases intestinal damage in the acute phase of rat TNB-colitis. Eur. J. Clin. Invest. 31:2001;234-239.
63. McCafferty D.M., Sihota E., Muscara M., Wallace J.L., Sharkey K.A., Kubes P. Spontaneously developing chronic colitis in IL10/iNOS double-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G90-G99.
64. Kondo S., Toyokuni S., Iwasa Y., Tanaka T., Onodera H., Hiai H., Imamura M. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 27:1999;401-410.
65. Yea C.M., Cross A.R., Jones O.T. Purification and some properties of the 45 kDa diphenylene iodonium-binding flavoprotein of neutrophil NADPH oxidase. Biochem. J. 265:1990;95-100.
66. Stuehr D.J., Fasehun O.A., Kwon N.S., Gross S.S., Gonzalez J.A., Levi R., Nathan C.F. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5:1991;98-103.
67. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;4328-4332.
68. Turpaev K.T. Reactive oxygen species and regulation of gene expression. Biochemistry (Moscow). 67:2002;281-292.